To ensure that the p53 in these AML cell lines was wild type and functional, the three cell lines were treated with nutlin-3 and Mdm2 protein upregulation, an indication of p53 activity, was observed (Figure 1C). The gene discussed is TP53; the disease is acute myeloid leukemia.